Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center.
Tatiana A ShelkovnikovaAleksandra S MaksimovaNadezhda I RyumshinaOlga V MochulaValery K VaizovWladimir Yu UssovNina D AnfinogenovaPublished in: Journal of imaging (2023)
The aim of study was to investigate the transformative effect of the COVID-19 pandemic on magnetic resonance imaging (MRI) services in one tertiary cardiovascular center. The retrospective observational cohort study analyzed data of MRI studies ( n = 8137) performed from 1 January 2019 to 1 June 2022. A total of 987 patients underwent contrast-enhanced cardiac MRI (CE-CMR). Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. The annual absolute numbers and rates of CE-CMR procedures in our center significantly increased from 2019 to 2022 ( p -value < 0.05). The increasing temporal trends were observed in hypertrophic cardiomyopathy (HCMP) and myocardial fibrosis ( p -value < 0.05). The CE-CMR findings of myocarditis, acute myocardial infarction, ischemic cardiomyopathy, HCMP, postinfarction cardiosclerosis, and focal myocardial fibrosis prevailed in men compared with the corresponding values in women during the pandemic ( p -value < 0.05). The frequency of myocardial fibrosis occurrence increased from ~67% in 2019 to ~84% in 2022 ( p -value < 0.05). The COVID-19 pandemic increased the need for MRI and CE-CMR. Patients with a history of COVID-19 had persistent and newly occurring symptoms of myocardial damage, suggesting chronic cardiac involvement consistent with long COVID-19 requiring continuous follow-up.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- left ventricular
- diffusion weighted
- diffusion weighted imaging
- sars cov
- coronavirus disease
- computed tomography
- magnetic resonance
- hypertrophic cardiomyopathy
- acute myocardial infarction
- healthcare
- coronary artery disease
- cross sectional
- chronic kidney disease
- primary care
- heart failure
- end stage renal disease
- electronic health record
- polycystic ovary syndrome
- type diabetes
- ejection fraction
- percutaneous coronary intervention
- liver fibrosis
- peritoneal dialysis
- acute coronary syndrome
- insulin resistance
- dual energy
- pregnant women
- atrial fibrillation
- newly diagnosed
- brain injury
- prognostic factors
- respiratory syndrome coronavirus